Biomet Revenue and Competitors
Estimated Revenue & Valuation
- Biomet's estimated annual revenue is currently $9.3M per year.
- Biomet's estimated revenue per employee is $251,000
Employee Data
- Biomet has 37 Employees.
- Biomet grew their employee count by 6% last year.
Biomet's People
Name | Title | Email/Phone |
---|---|---|
1 | Managing Director | Reveal Email/Phone |
Biomet Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Biomet?
M4 is a orthopaedics company, distributing Biomet products in Rio de Janeiro, Minas Gerais, Espirito Santoe Mato Grasso do Sul.
keywords:N/AN/A
Total Funding
37
Number of Employees
$9.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biomet News
2022-04-19 - Zimmer Biomet Holdings Inc. stock falls Wednesday, underperforms market
Zimmer Biomet Holdings Inc. stock falls Wednesday, underperforms market. Published: April 27, 2022 at 5:30 p.m. ET. By. MarketWatch Automation.
2022-04-19 - Zimmer Biomet's mymobility is recognized as "The Care ...
Zimmer Biomet's mymobility is recognized as "The Care Management Initiative of the Year" by the 2022 Healthcare Asia Medtech Awards.
2022-04-17 - Zimmer Biomet Holdings Inc. stock falls Tuesday, underperforms market
Shares of Zimmer Biomet Holdings Inc. ZBH, -1.02% slid 2.86% to $124.15 Tuesday, on what proved to be an all-around poor trading session for...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 37 | -16% | N/A |
#2 | $4.7M | 37 | -14% | N/A |
#3 | $4.9M | 37 | 0% | N/A |
#4 | $4.3M | 37 | 3% | N/A |
#5 | $4.4M | 37 | -7% | N/A |